Virbac SA
VIRP.PA · PAR
Bulios Fair Price
390.55 €
25.8% upside
Current Price
310.5 €
According to Bulios Fair Price, VIRP.PA is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Virbac SA is a French pharmaceutical company specializing in the development, manufacturing, and distribution of veterinary medicines. Founded in 1968 and headquartered in Carros, France, Virbac is known for its wide range of products for animals, including medications, vaccines, and diagnostic tools aimed at improving animal health and preventing diseases. The company operates globally, and its products are designed for both pets and livestock.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Paul Martingell
Employees
6,442
Headquarters
Carros
Upcoming events
Earnings
Upcoming earnings report